About the role
Mavericks Wanted
When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on
In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible.
Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work.
What You'll Do
We are seeking a strategically minded and analytically gifted Director of Commercial Analytics & Insights to join our growing commercial team. This is a high-impact role responsible for planning and leading core insights functions —market research, competitive intelligence, data and sales analytics, and forecasting— to guide launch planning and strategic decision-making for a rare disease product.
The Director will be the primary lead for all Commercial Analytics & Insights activities for a specific rare disease therapeutic, and will indirectly manage a small team of analytics and insights professionals.
Responsibilities
- Commercial Analytics
- Develop and execute an integrated analytics strategy that supports pre-launch efforts and evolves into post-launch optimization
- Analyze market trends, HCP and patient engagement data, and early launch metrics to guide brand and access strategies
- Monitor and interpret key performance indicators such as new patient starts, conversion, adherence, and call activity
- Influence sales analytics framework to support field force performance, territory optimization, and incentive compensation strategies
- Forecasting
02 Aplyr's read
BridgeBio Pharma is a dynamic biotechnology firm dedicated to tackling genetic diseases and cancers, attracting professionals passionate about impactful medical advancements.
What's promising
- •BridgeBio focuses on innovative treatments for genetic diseases, offering significant potential for groundbreaking medical advancements.
- •The company has a robust pipeline with multiple late-stage clinical trials, indicating strong future growth prospects.
- •BridgeBio's strategic partnerships enhance its research capabilities and expand its therapeutic reach.
What to watch
- •The company faces high financial risk due to significant R&D expenditures without guaranteed success.
- •BridgeBio operates in a highly competitive market with numerous established players.
- •Regulatory hurdles for drug approvals can delay product launches and impact revenue.
Why BridgeBio Pharma
- •BridgeBio's focus on genetic diseases and cancers sets it apart in the biotechnology sector.
- •The company's decentralized model allows for nimble and efficient project management.
- •BridgeBio's commitment to rare diseases addresses unmet medical needs, differentiating its mission.
Aplyr’s read is generated by AI from public sources. Was it useful?
03 About BridgeBio Pharma
BridgeBio is a biotechnology company focused on developing and commercializing medicines for genetic diseases and cancers.
04 Similar roles
Executive Director, Commercial Insights & Analytics - Ophthalmology
Regeneron
Executive Director, Commercial Insights & Analytics - Neurology
Regeneron
Director / Senior Director, Commercial Analytics & Insights
BridgeBio Pharma
Manager, Integrated Analytics, Global Commercial Insights & Analytics, Immunology
Johnson & Johnson
Commercial Analytics & Insights Senior Manager; Responsable principal(e) de l'analyse et des études commerciales
Procter & Gamble
Vice President, Insights, Analytics & Digital US Commercial Lead
argenx
